IDEAYA Biosciences (NASDAQ: IDYA) has elected Yujiro S. Hata as Chairman of its Board of Directors, according to a press release. Hata, who founded the South San Francisco-based oncology company, continues in his current role as President and Chief Executive Officer and remains a board member.

Terry Rosen, Ph.D., will serve as Lead Independent Director of IDEAYA's board following the leadership change.

"Since founding IDEAYA over a decade ago, Yujiro's vision, passion for the mission, and leadership have been core to the evolution of IDEAYA from an early science-driven start-up to a leading precision medicine oncology company with an extensive clinical pipeline where commercial launch preparations are underway," Rosen said.

Hata said he is "grateful to the board for the opportunity to serve and advance IDEAYA's vision to drive forward our important cancer research and deliver breakthrough therapies for patients to address high unmet medical needs in cancer."